Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001787306-26-000040
Filing Date
2026-05-06
Accepted
2026-05-06 16:06:55
Documents
65
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q arqt-20260331.htm   iXBRL 10-Q 892359
2 EX-31.1 exhibit311ceoq12026.htm EX-31.1 10771
3 EX-31.2 exhibit312cfoq12026.htm EX-31.2 10739
4 EX-32.1 exhibit321ceocfoq12026.htm EX-32.1 7102
  Complete submission text file 0001787306-26-000040.txt   6033152

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arqt-20260331.xsd EX-101.SCH 46894
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arqt-20260331_cal.xml EX-101.CAL 67704
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arqt-20260331_def.xml EX-101.DEF 203272
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arqt-20260331_lab.xml EX-101.LAB 612717
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arqt-20260331_pre.xml EX-101.PRE 415277
69 EXTRACTED XBRL INSTANCE DOCUMENT arqt-20260331_htm.xml XML 794436
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

EIN.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39186 | Film No.: 26948334
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)